Seegene’s saliva test for COVID-19 is just as effective as NPS test
Published on: PR Newswire A new study shows that the less-invasive saliva test for COVID-19 gives just as accurate results as those of the nasopharyngeal
Seegene develops world first COVID-19 variant test capable of identifying origins of virus variants
Published on: PR Newswire SEEGENE LAUNCHES FIRST MULTIPLEX TEST TO IDENTIFY COVID-19 MUTANTS THE MANUFACTURER OF COVID-19 TESTS CONTINUOUSLY FOLLOWS THE SPREAD OF THE VARIANTS
Seegene introduces a High-throughput 8-plex Test for Flu A, Flu B, RSV and COVID-19 with dual internal controls
SEOUL, South Korea, Sept. 8, 2020 /PRNewswire/ — Seegene, Inc. introduced a single tube real-time RT-PCR assay, Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay, which simultaneously detects and differentiates Flu A,
Seegene’s Allplex™ 2019-nCoV Assay receives FDA Emergency Use Authorization
Published on: 매일경제 한국경제 PR Newswire 조선일보 SEOUL, Korea, Apr 22, 2020 – Seegene, Inc. announced that U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA)
Seegene exported 10 Million COVID-19 Diagnostic Tests to Over 60 countries
Published on: PR Newswire ABC News Seegene, Inc., the leading multiplex diagnostic assay developer, today announced that the company has exported over 10 million tests of
Seegene Highlights Clinical Automated Nucleic Acid Extraction System at ASM Microbe 2019
2019 American Society for Microbiology Microbe Conference: Booth #1062 Published on: PR Newswire SEOUL, South Korea, June 21, 2019 /PRNewswire/ — Seegene Inc. (096530.KQ), a leading developer